| 000 | 01913 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517101050.0 | ||
| 264 | 0 | _c20170901 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1471-2164 | ||
| 024 | 7 |
_a10.1186/s12864-016-2777-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPop, Mihai | |
| 245 | 0 | 0 |
_aIndividual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment. _h[electronic resource] |
| 260 |
_bBMC genomics _c06 2016 |
||
| 300 |
_a440 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 |
_aDiarrhea _xdrug therapy |
| 650 | 0 | 4 |
_aEnterotoxigenic Escherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Microbiome _xdrug effects |
| 650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetagenome |
| 650 | 0 | 4 |
_aMetagenomics _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRNA, Ribosomal, 16S |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPaulson, Joseph N | |
| 700 | 1 | _aChakraborty, Subhra | |
| 700 | 1 | _aAstrovskaya, Irina | |
| 700 | 1 | _aLindsay, Brianna R | |
| 700 | 1 | _aLi, Shan | |
| 700 | 1 | _aBravo, Héctor Corrada | |
| 700 | 1 | _aHarro, Clayton | |
| 700 | 1 | _aParkhill, Julian | |
| 700 | 1 | _aWalker, Alan W | |
| 700 | 1 | _aWalker, Richard I | |
| 700 | 1 | _aSack, David A | |
| 700 | 1 | _aStine, O Colin | |
| 773 | 0 |
_tBMC genomics _gvol. 17 _gp. 440 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12864-016-2777-0 _zAvailable from publisher's website |
| 999 |
_c26104319 _d26104319 |
||